UNSPSC 51283928: Sulfaquinoxaline

This classification denotes a sulfonamide anti-infective agent with the molecular formula C14H12N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WNW8115TM9, chemically known as sulfanilamide, n(sup1)-2-quinoxalinyl- but generally known as sulfaquinoxaline, which bears US NIH Compound Identifier 5338. European Medicines Agency schedules Sulfaquinoxaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10725MIG. The term SULFAQUINOXALINE is an International Non-Proprietary Name.

UNSPSC 51283928 Sulfaquinoxaline is a Commodity code that nominally designates a veterinary antimicrobial compound, yet recent state and local procurement activity under this code does not reflect actual purchases of sulfaquinoxaline itself. Instead, the code appears in solicitations for medical and pharmaceutical supplies spanning naloxone, first-aid equipment, generic multi-source pharmaceuticals, and over-the-counter products—none of which are sulfaquinoxaline. This mismatch suggests either miscoding of opportunities in procurement systems or a taxonomic misalignment between the UNSPSC code designation and current buying patterns. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire and rescue divisions (City of Tampa Fire Department), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local participants). The actual scope of work being procured includes emergency response and clinical supplies, pharmaceutical manufacturing and distribution, and health-related consumables.

Recent opportunities span Florida, Texas, Minnesota, and Oregon, with no clear concentration in any single state. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB60459723LAS, due July 26, 2023), the City of Tampa's IFB for medical and first-aid supplies to support the Fire Department Rescue Division, 169 line items with an estimated contract amount of $700,000.00 (26P00145, due March 13, 2026), the Texas HHS Commission's RFI on direct-to-manufacturer pharmaceutical prescriptions (HHS0017013, due April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities (S1070000015802, due March 26, 2026). The code does not appear to reflect procurement of the veterinary antimicrobial product its UNSPSC name suggests.